About The Peptide Guide

The Peptide Guide (thepeptideguide.ca) is a Canadian peptide research and education resource founded by Rachel Gibb and launched in 2026. Its purpose is straightforward: give the Canadian research community one place where compound information, practical technique, and sourcing context are accurate, current, and written to be understood.

Editorial standards

• Research framing, always. Dosing and protocol information describes published research literature and clinical trial designs. It is never presented as a recommendation, and first-person instructional language is never used.
• Citations over claims. Mechanism and efficacy statements reference published studies, linked to PubMed where available. Where evidence is thin — Russian-only literature, preclinical-only data — the page says so plainly.
• Plain language first, depth second. Every page opens with a summary a newcomer can understand, then provides the technical detail an experienced researcher expects. Technical terms are defined on first use and in the glossary.
• Honest side-effect reporting. Observed adverse effects are stated as prominently as mechanisms.

The Research Use Only commitment

Everything on this site concerns compounds sold for laboratory research. Nothing here is medical advice, no content implies therapeutic outcomes for humans, and pages covering compounds that are prescription drugs in Canada say so explicitly. The full disclaimer appears in the footer of every page.

How this site is funded

Two disclosed relationships: links to My Peptide Protocol (the companion tracking and calculator app, same founder) and to Regen BioSignals (featured Canadian vendor, referral relationship). Other vendors and apps in our directories are listed for completeness without payment or endorsement. Directory information is compiled from vendors’ own published materials and dated accordingly.

Corrections

Errors get fixed, and pages carry modification dates. If something on this site is wrong or outdated, we want to know.